Agilent Technologies (NYSE:A) issued an update on its FY18 earnings guidance on Wednesday morning. The company provided EPS guidance of $2.62-2.68 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.59. The company issued revenue guidance of $4.885-4.905 billion, compared to the consensus revenue estimate of $4.75 billion.Agilent Technologies also updated its Q2 guidance to $0.61-0.63 EPS.
Agilent Technologies (NYSE:A) traded up $1.36 during midday trading on Wednesday, reaching $69.70. The company had a trading volume of 3,632,650 shares, compared to its average volume of 2,254,274. The company has a market capitalization of $22,410.00, a P/E ratio of 33.19, a PEG ratio of 2.07 and a beta of 1.28. The company has a quick ratio of 2.85, a current ratio of 3.30 and a debt-to-equity ratio of 0.37. Agilent Technologies has a fifty-two week low of $50.56 and a fifty-two week high of $75.00.
Agilent Technologies (NYSE:A) last released its quarterly earnings data on Monday, November 20th. The medical research company reported $0.67 EPS for the quarter, beating analysts’ consensus estimates of $0.62 by $0.05. The business had revenue of $1.19 billion during the quarter, compared to the consensus estimate of $1.17 billion. Agilent Technologies had a return on equity of 16.95% and a net margin of 15.30%. The firm’s revenue was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.59 earnings per share. equities research analysts predict that Agilent Technologies will post 2.58 EPS for the current year.
In other news, CEO Michael R. Mcmullen sold 21,850 shares of the company’s stock in a transaction dated Monday, January 29th. The stock was sold at an average price of $75.00, for a total transaction of $1,638,750.00. Following the completion of the transaction, the chief executive officer now directly owns 324,687 shares of the company’s stock, valued at $24,351,525. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Michael R. Mcmullen sold 43,703 shares of the company’s stock in a transaction dated Friday, January 5th. The stock was sold at an average price of $70.00, for a total value of $3,059,210.00. Following the transaction, the chief executive officer now directly owns 302,837 shares of the company’s stock, valued at $21,198,590. The disclosure for this sale can be found here. Over the last three months, insiders sold 219,991 shares of company stock valued at $15,468,795.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.